SMILE CARE

Basma Adeem Medical Co.

9626StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operating Summary
Revenue	45.46M	33.92M	26.52M	21.92M
Cost of Revenue	32.14M	22.90M	18.19M	15.02M
Gross Profit	13.31M	11.02M	8.33M	6.90M
SG&A	5.26M	4.06M	2.48M	2.57M
Operating Expenses	5.26M	4.06M	2.74M	2.69M
Operating Income	8.06M	6.96M	5.59M	4.21M
Interest Income	844.11K	103.31K	—	—
Interest Expense	-752.13K	-338.04K	-360.26K	-285.35K
Other Income/Expense	65.97K	56.75K	-301.50K	—
Pretax Income	8.25M	6.78M	5.06M	3.92M
Income Tax	944.77K	481.95K	186.49K	139.85K
Net Income	7.30M	6.30M	4.87M	3.78M
EBITDA	9.09M	7.59M	6.20M	4.54M
EBIT	8.06M	6.96M	5.59M	4.21M
EPS (Basic)	0.40	0.55	0.51	—
EPS (Diluted)	0.40	0.55	0.51	—
Margins & Efficiency
Gross Margin %	+29.3%	+32.5%	+31.4%	+31.5%
EBITDA Margin %	+20.0%	+22.4%	+23.4%	+20.7%
Net Margin %	+16.1%	+18.6%	+18.4%	+17.3%
Revenue & Income
Revenue	45.46M	33.92M	26.52M	21.92M
Revenue Growth (YoY)	+34.0%	+27.9%	+21.0%	—
Interest & Investment Income	844.11K	103.31K	—	—
Gain (Loss) on Sale of Assets	35.44K	—	—	—
Expenses & Provisions
Advertising Expenses	314.45K	154.63K	—	—
Cost of Revenue	32.14M	22.90M	18.19M	15.02M
Selling, General & Admin	5.26M	4.06M	2.48M	2.57M
Operating Expenses	5.26M	4.06M	2.74M	2.69M
Interest Expense	-752.13K	-338.04K	-360.26K	-285.35K
Other Non Operating Income (Expenses)	65.97K	56.75K	-301.50K	—
D&A For EBITDA	1.03M	0.62M	0.61M	0.33M
Profitability & Returns
Gross Profit	13.31M	11.02M	8.33M	6.90M
Gross Margin	+29.3%	+32.5%	+31.4%	+31.5%
EBIT	8.06M	6.96M	5.59M	4.21M
EBIT Margin	+17.7%	+20.5%	+21.1%	+19.2%
EBITDA	9.09M	7.59M	6.20M	4.54M
EBITDA Margin	+20.0%	+22.4%	+23.4%	+20.7%
EBT Excluding Unusual Items	8.21M	6.78M	4.93M	3.92M
Pretax Income	8.25M	6.78M	5.06M	3.92M
Operating Income	8.06M	6.96M	5.59M	4.21M
Operating Margin	+17.7%	+20.5%	+21.1%	+19.2%
Profit Margin	+16.1%	+18.6%	+18.4%	+17.3%
Net Income	7.30M	6.30M	4.87M	3.78M
Net Income to Common	7.30M	6.30M	4.87M	3.78M
Net Income Growth	+15.9%	+29.4%	+28.7%	—
Income Tax Expense	944.77K	481.95K	186.49K	139.85K
Effective Tax Rate	+11.5%	+7.1%	+3.7%	+3.6%
Per Share & Capital
EPS (Basic)	0.40	0.55	0.51	—
EPS (Diluted)	0.40	0.55	0.51	—
EPS Growth	-25.8%	+6.4%	—	—
Shares Change (YoY)	0.56	0.22	—	—
Shares Outstanding (Basic)	18.04M	11.55M	9.50M	—
Shares Outstanding (Diluted)	18.04M	11.55M	9.50M	—
Free Cash Flow	4.76M	6.66M	4.07M	5.24M
Free Cash Flow Margin	+10.5%	+19.6%	+15.3%	+23.9%
Free Cash Flow Per Share	0.26	0.58	0.43	—
Payout Ratio	—	—	—	+95.2%
Supplemental
Other Unusual Items	—	-2.04K	129.80K	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operating Summary
Revenue	45.46M	33.92M	26.52M	21.92M
Cost of Revenue	32.14M	22.90M	18.19M	15.02M
Gross Profit	13.31M	11.02M	8.33M	6.90M
SG&A	5.26M	4.06M	2.48M	2.57M
Operating Expenses	5.26M	4.06M	2.74M	2.69M
Operating Income	8.06M	6.96M	5.59M	4.21M
Interest Income	844.11K	103.31K	—	—
Interest Expense	-752.13K	-338.04K	-360.26K	-285.35K
Other Income/Expense	65.97K	56.75K	-301.50K	—
Pretax Income	8.25M	6.78M	5.06M	3.92M
Income Tax	944.77K	481.95K	186.49K	139.85K
Net Income	7.30M	6.30M	4.87M	3.78M
EBITDA	9.09M	7.59M	6.20M	4.54M
EBIT	8.06M	6.96M	5.59M	4.21M
EPS (Basic)	0.40	0.55	0.51	—
EPS (Diluted)	0.40	0.55	0.51	—
Margins & Efficiency
Gross Margin %	+29.3%	+32.5%	+31.4%	+31.5%
EBITDA Margin %	+20.0%	+22.4%	+23.4%	+20.7%
Net Margin %	+16.1%	+18.6%	+18.4%	+17.3%
Revenue & Income
Revenue	45.46M	33.92M	26.52M	21.92M
Revenue Growth (YoY)	+34.0%	+27.9%	+21.0%	—
Interest & Investment Income	844.11K	103.31K	—	—
Gain (Loss) on Sale of Assets	35.44K	—	—	—
Expenses & Provisions
Advertising Expenses	314.45K	154.63K	—	—
Cost of Revenue	32.14M	22.90M	18.19M	15.02M
Selling, General & Admin	5.26M	4.06M	2.48M	2.57M
Operating Expenses	5.26M	4.06M	2.74M	2.69M
Interest Expense	-752.13K	-338.04K	-360.26K	-285.35K
Other Non Operating Income (Expenses)	65.97K	56.75K	-301.50K	—
D&A For EBITDA	1.03M	0.62M	0.61M	0.33M
Profitability & Returns
Gross Profit	13.31M	11.02M	8.33M	6.90M
Gross Margin	+29.3%	+32.5%	+31.4%	+31.5%
EBIT	8.06M	6.96M	5.59M	4.21M
EBIT Margin	+17.7%	+20.5%	+21.1%	+19.2%
EBITDA	9.09M	7.59M	6.20M	4.54M
EBITDA Margin	+20.0%	+22.4%	+23.4%	+20.7%
EBT Excluding Unusual Items	8.21M	6.78M	4.93M	3.92M
Pretax Income	8.25M	6.78M	5.06M	3.92M
Operating Income	8.06M	6.96M	5.59M	4.21M
Operating Margin	+17.7%	+20.5%	+21.1%	+19.2%
Profit Margin	+16.1%	+18.6%	+18.4%	+17.3%
Net Income	7.30M	6.30M	4.87M	3.78M
Net Income to Common	7.30M	6.30M	4.87M	3.78M
Net Income Growth	+15.9%	+29.4%	+28.7%	—
Income Tax Expense	944.77K	481.95K	186.49K	139.85K
Effective Tax Rate	+11.5%	+7.1%	+3.7%	+3.6%
Per Share & Capital
EPS (Basic)	0.40	0.55	0.51	—
EPS (Diluted)	0.40	0.55	0.51	—
EPS Growth	-25.8%	+6.4%	—	—
Shares Change (YoY)	0.56	0.22	—	—
Shares Outstanding (Basic)	18.04M	11.55M	9.50M	—
Shares Outstanding (Diluted)	18.04M	11.55M	9.50M	—
Free Cash Flow	4.76M	6.66M	4.07M	5.24M
Free Cash Flow Margin	+10.5%	+19.6%	+15.3%	+23.9%
Free Cash Flow Per Share	0.26	0.58	0.43	—
Payout Ratio	—	—	—	+95.2%
Supplemental
Other Unusual Items	—	-2.04K	129.80K	—